|
|
Article: Auriga Laboratories Launches Aquoral(TM) for Xerostomia or "Dry Mouth".
- Article from:
- Business Wire
- Article date:
- February 28, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Novel Formulation Marks Entrance into $1 Billion Xerostomia Marketplace
NORCROSS, Ga. -- Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of acute respiratory diseases and dermatological conditions, announces the launch of Aquoral[TM] for the treatment of xerostomia, also known as "dry mouth." This new, patent-pending, prescription-only product introduction marks Auriga's entrance into the $1 billion xerostomia marketplace.
Beginning in March, Aquoral will be rolled out to high-prescribing physicians nationwide via Auriga's expanding 200-member national sales force. Auriga will also launch ...